Zobrazeno 1 - 10
of 17
pro vyhledávání: '"W H, Cooner"'
Autor:
R G, Middleton, I M, Thompson, M S, Austenfeld, W H, Cooner, R J, Correa, R P, Gibbons, H C, Miller, J E, Oesterling, M I, Resnick, S R, Smalley
Publikováno v:
The Journal of urology. 154(6)
The American Urological Association convened the Prostate Cancer Clinical Guidelines Panel to analyze the literature regarding available methods for treating locally confined prostate cancer, and to make practice policy recommendations based on the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44df558007c1f2a67a51f733668e5d9e
https://pubmed.ncbi.nlm.nih.gov/7500479
https://pubmed.ncbi.nlm.nih.gov/7500479
Publikováno v:
The Journal of urology. 153(4)
Several investigations have determined that the serum prostate specific antigen (PSA) concentration is dependent upon patient age and, as a result, reference ranges wider than 0.0 to 4.0 ng./ml. have been suggested for men 60 years old or older. To d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff83c847efdbc6d8ff54f2708a465b72
https://pubmed.ncbi.nlm.nih.gov/7532725
https://pubmed.ncbi.nlm.nih.gov/7532725
Autor:
W. H. Cooner
Publikováno v:
Screening des Prostatakarzinoms ISBN: 9783642783197
Es ist wichtig, zwischen einem Prostata-Screening bei einer nichtselektierten Gruppe von asymptomatischen Mannern und Krebsfruherkennungsmasnahmen bei symptomatischen Patienten, die sich in arztliche Behandlung begeben, zu unterscheiden. Patienten in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3470c06db16d50ed46cc32337a41310
https://doi.org/10.1007/978-3-642-78318-0_22
https://doi.org/10.1007/978-3-642-78318-0_22
Autor:
W H, Cooner
Publikováno v:
Journal of the South Carolina Medical Association (1975). 90(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9687dbee13c59abc21f09e6d76317f03
https://pubmed.ncbi.nlm.nih.gov/8028290
https://pubmed.ncbi.nlm.nih.gov/8028290
Autor:
W H, Cooner
Publikováno v:
The Journal of urology. 151(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e40007d9080b47377d5748cfe6b27db0
https://pubmed.ncbi.nlm.nih.gov/7504744
https://pubmed.ncbi.nlm.nih.gov/7504744
Autor:
W. H. Cooner
Publikováno v:
World Journal of Urology. 11
In a patient population, coordinated use of digital rectal examination and prostate-specific antigen can alert the physician as to the possible existence of prostate cancer. If both are used as first-line studies, abnormality of either can then direc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c267067815598b6f99e18a81e1f662
https://doi.org/10.1007/bf00185071
https://doi.org/10.1007/bf00185071
Prostate-specific antigen and transrectal ultrasound of the prostate in detection of prostate cancer
Autor:
W H, Cooner
Publikováno v:
Clinical and investigative medicine. Medecine clinique et experimentale. 16(6)
Detection of prostate cancer can be enhanced over the level historically obtained by digital rectal examination through the combined use of serum prostate-specific antigen and digital rectal examination, followed by transrectal ultrasonic examination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::599d32da4e26b8522a5ed33afce94fe1
https://pubmed.ncbi.nlm.nih.gov/7516834
https://pubmed.ncbi.nlm.nih.gov/7516834
Publikováno v:
The Urologic clinics of North America. 20(4)
Prostate Specific Antigen (PSA) is the most accurate serum marker for cancer of the prostate. However, sensitivity and specificity are suboptimal, especially at the intermediate levels between 4.1 and 10.0 ng/ml (monoclonal). For intermediate PSA lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4cd5ee7b4193316a5046a878dad42118
https://pubmed.ncbi.nlm.nih.gov/7505973
https://pubmed.ncbi.nlm.nih.gov/7505973
Autor:
W H, Cooner
Publikováno v:
The Urologic clinics of North America. 20(4)
It is evident that the ideal tumor marker is not, nor should it be, a perfect tumor marker given the present level of our knowledge about prostate cancer. Further refinement of our information about prognosis and optimal treatment of this disease wil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e3c039309d2206f5d555ecb6e53fc0c
https://pubmed.ncbi.nlm.nih.gov/8273265
https://pubmed.ncbi.nlm.nih.gov/8273265
Publikováno v:
Cancer. 70
There are a number of similarities between benign prostatic hyperplasia (BPH) and cancer. Both display a parallel increase in prevalence with patient age according to autopsy studies (86.2% and 43.6%, respectively, by the ninth decade), although canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6dd92c57830e6a07a4672f4297bee512
https://pubmed.ncbi.nlm.nih.gov/1376199
https://pubmed.ncbi.nlm.nih.gov/1376199